ALBA MORROW: Open Payments
NPI 1386383271 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 20 payments from 11 companies in 2025. Trend: 2023 $361 · 2024 $299 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $120 |
| Tandem Diabetes Care, Inc. | 3 | $108 |
| Insulet Corporation | 2 | $97 |
| Corcept Therapeutics | 4 | $74 |
| Dexcom, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $43 |
| Sequel Med Tech, LLC | 2 | $40 |
| Novo Nordisk Inc | 1 | $27 |
| Ascendis Pharma Endocrinology Inc | 1 | $23 |
| Phadia US Inc. | 1 | $21 |
Products named: EVENITY, t:slim X2 Insulin Pump with Control-IQ, Omnipod, Korlym, Dexcom G6 Transmitter, MOUNJARO, TWIIST, Rybelsus.
Industry payments across FL — which companies pay providers there.
